ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 634.00
-30.00 (-4.52%)
Feb 26, 2026, 9:50 AM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 78.73 billion as of February 25, 2026. Its market cap has decreased by -54.36% in one year.
Market Cap
78.73B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
634.00
Market Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 78.73B, an increase of 152.34%. That is a compound annual growth rate of 3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 78.73B | 10.48% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 202.61B |
| Macrogen | 200.78B |
| MedPacto | 199.48B |
| ENCell | 185.96B |
| GeneOne Life Science | 125.76B |
| IMB Dx | 114.95B |
| iNtRON Biotechnology | 111.58B |
| CG Invites | 95.43B |